Researcher Patrick Grant, Ph.D., at Florida Atlantic University is utilizing epigenetics to develop better treatments for childhood acute lymphoblastic leukemia (ALL), a rare and aggressive

Researcher Diana J. Azzam and her team conducted a study on the feasibility of functional precision medicine (FPM) in treating relapsed or refractory pediatric cancers.

Researcher Qing-Xiang Amy Sang at Florida State University is pioneering a study to develop a reliable model for atypical teratoid/rhabdoid tumor (ATRT), a rare and

Researcher Matthew D. Hall, MD, at Miami Cancer Institute led a study examining the long-term effects of radiation therapy on brain development in children with

Damon Reed and his team at Moffitt Cancer Center are leading a phase II clinical trial investigating evolutionary inspired therapy for treating fusion-positive metastatic rhabdomyosarcoma.

Researcher Tamarah J. Westmoreland at Nemours Children’s Health is leading a groundbreaking study exploring the oncolytic potential of the Zika virus (ZIKV) in treating high-risk

Researcher Annette R. Khaled at the University of Central Florida College of Medicine led a study identifying Chaperonin-containing TCP-1 (CCT/TRiC) as a promising therapeutic and

Researcher Jonathan Licht at University of Florida Health, led a study and identified how a specific mutation in the NSD2 gene (E1099K) contributes to relapse

Researcher Regina M. Graham at the University of Miami Miller School of Medicine led a study exploring the potential of carbon dots (CDs) in treating

Researcher Mildred Acevedo-Duncan, Ph.D., at the University of South Florida is leading a study on the potential of PKC-i inhibitors in preventing the growth of